5DM4
Crystal structure of the plantazolicin methyltransferase BpumL in complex with pentazolic desmethylPZN analog and SAH
Summary for 5DM4
| Entry DOI | 10.2210/pdb5dm4/pdb |
| Related | 5DLY 5DM1 5DM2 |
| Descriptor | Methyltransferase domain family, S-ADENOSYL-L-HOMOCYSTEINE, GLYCEROL, ... (5 entities in total) |
| Functional Keywords | n-methyltransferase, plantazolicin, pentazolic desmethylpzn analog, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
| Biological source | Bacillus pumilus ATCC 7061 |
| Total number of polymer chains | 1 |
| Total formula weight | 31415.75 |
| Authors | Hao, Y.,Nair, S.K. (deposition date: 2015-09-07, release date: 2015-09-23, Last modification date: 2024-03-13) |
| Primary citation | Hao, Y.,Blair, P.M.,Sharma, A.,Mitchell, D.A.,Nair, S.K. Insights into methyltransferase specificity and bioactivity of derivatives of the antibiotic plantazolicin. Acs Chem.Biol., 10:1209-1216, 2015 Cited by PubMed Abstract: Peptide antibiotics represent a class of conformationally constrained natural products of growing pharmaceutical interest. Plantazolicin (PZN) is a linear, polyheterocyclic natural product with highly selective and potent activity against the anthrax-causing bacterium, Bacillus anthracis. The bioactivity of PZN is contingent on dimethylation of its N-terminal Arg residue by an S-adenosylmethionine-dependent methyltransferase. Here, we explore the substrate tolerances of two homologous PZN methyltransferases by carrying out kinetic analyses of the enzymes against a synthetic panel of truncated PZN analogs containing the N-terminal Arg residue. X-ray cocrystal structures of the PZN methyltransferases with each of these heterocycle-containing substrates provide a rationale for understanding the strict substrate specificity of these enzymes. Kinetic studies of structure-guided, site-specific variants allowed for the assignment of residues governing catalysis and substrate scope. Microbiological testing further revealed that upon dimethylation of the N-terminal Arg, a pentaheterocyclized PZN analog retained potent anti-B. anthracis activity, nearly equal to that of full-length PZN. These studies may be useful in the biosynthetic engineering of natural product analogs with different bioactivity profiles, as demonstrated by our identification of a truncated plantazolicin derivative that is active against methicillin-resistant Staphylococcus aureus (MRSA). PubMed: 25635336DOI: 10.1021/cb501042a PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.75 Å) |
Structure validation
Download full validation report






